At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment and Prediction of the Effectiveness of Mepolizumab Anti-IL-5/IL5R Inhibitors in a Real-world Setting
In Brief
An observational study evaluating IL5/IL5R Antagonists for Severe Asthma. Completed, enrolled 108 participants across 1 site.
Detailed Summary
The goal of this observational study is to assess the response to treatment, in patients 18 years and older diagnosed with severe asthma in whom an IL5/IL5R antagonists was initiated between 2012 and 2020. The main question\[s\] it aims to answer are: * What is the response rate after one year of treatment with IL5/IL5R antagonists. * What is the response and remission rate after one year of treatment with IL5/IL5R antagonists in subjects who fullfilled the original randomized control trials (RCTs) inclusion criteria compared with those who did not.
Study Details
Timeline
Interventions
Treatment with IL5/IL5R antagonists for one year